Veer Bhavnagri

Insider Reports History

Entity
Individual
Location
C/O Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA
Signature
/s/Veer Bhavnagri
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Veer Bhavnagri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. General Counsel Common Stock 556K $1.77M $3.17 Mar 14, 2023 Direct

Insider Reports Filed by Veer Bhavnagri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Mar 14, 2023 1 -$134K 4 Mar 16, 2023 General Counsel
ALLO Allogene Therapeutics, Inc. Feb 13, 2023 1 -$20.6K 4 Feb 14, 2023 General Counsel
ALLO Allogene Therapeutics, Inc. Jan 17, 2023 1 -$21.1K 4 Jan 18, 2023 General Counsel
ALLO Allogene Therapeutics, Inc. Dec 15, 2022 1 -$42.2K 4 Dec 19, 2022 General Counsel
ALLO Allogene Therapeutics, Inc. Mar 23, 2022 2 $0 4 Mar 25, 2022 General Counsel
ALLO Allogene Therapeutics, Inc. Mar 15, 2022 1 -$68K 4 Mar 17, 2022 General Counsel
ALLO Allogene Therapeutics, Inc. Sep 15, 2021 3 -$112K 4 Sep 17, 2021 General Counsel
ALLO Allogene Therapeutics, Inc. Aug 16, 2021 3 -$93.6K 4 Aug 17, 2021 General Counsel
ALLO Allogene Therapeutics, Inc. Jul 15, 2021 3 -$96.4K 4 Jul 16, 2021 General Counsel
ALLO Allogene Therapeutics, Inc. Jun 15, 2021 3 -$115K 4 Jun 16, 2021 General Counsel
ALLO Allogene Therapeutics, Inc. May 18, 2021 3 -$139K 4 May 20, 2021 General Counsel
ALLO Allogene Therapeutics, Inc. May 17, 2021 3 -$130K 4 May 17, 2021 General Counsel